Skip to main content
OpenTrials
Completed

NCT Number: NCT01809678

Yoga as a Complementary Therapy for Smoking Cessation

This study examines the efficacy of yoga as a complementary therapy for smoking cessation

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

The Miriam Hospital

Providence, Rhode Island, 02906, United States

About this study

Despite the existence of effective medications for smoking cessation, approximately 50-80% of smokers attempt to quit without using pharmacotherapy. Efforts to encourage medication use during cessation attempts have met with mixed success. Many do not use medications because of concerns about side effects, contraindications that make medication use inappropriate, and individual preferences for chemical-free quit attempts. This leaves many smokers seeking an effective alternative to assist them in attempting to quit smoking. Each year, over 41% of smokers report failed attempts to quit smoking. Thus, effective non-pharmacological interventions to increase rates of successful cessation are greatly needed.

Our research, and the research of other investigators, has demonstrated that traditional (Western) exercise (e.g., brisk walking, bicycling) improves smokers' ability to successfully quit. Exercise may help smokers quit by reducing concerns regarding post-cessation weight gain, and by reducing nicotine withdrawal and enhancing mood. Recent research suggests that yoga is an acceptable and potentially effective alternative therapy for smoking cessation for several reasons: As a form of exercise, yoga shares many of the same properties as traditional (Western) aerobic exercise in that yoga has been shown to improve mood, physical fitness, weight control, self-image and quality of life in healthy and ill populations. Moreover, features of yoga, including a focus on breathing, mental concentration, meditation, stress reduction and enhanced mood are likely to have special relevance for smokers who are trying to quit. Thus, yoga may be particularly attractive as an alternative for individuals who either cannot use medications, or who choose not to use medications while quitting.

The proposed study will test the efficacy of Yoga as a complementary therapy for smoking cessation using a randomized, controlled study design. Adult smokers will be randomly assigned to either; 1) Yoga, or 2) an equal contact time Control group (CTL) given a health & wellness program to control for contact time. All participants will be provided (separately by treatment group assignment) with the same cognitive-behavioral Smoking Cessation Counseling (SCC). Smoking abstinence will be measured at the end of treatment (week 8) and at 3, 6 and 12 months follow-up. We hypothesize that abstinence will be significantly higher in the SCC+Yoga group compared to SCC+CTL. We will also test theoretically posited mediators of intervention efficacy (e.g., perceived stress, cognitive/perceptual changes), examine the cost-efficacy of the yoga intervention, and examine the relationship between maintenance of yoga practice during the post-treatment period and smoking status. This study builds on our programmatic line of research developing innovative, theory-driven smoking cessation therapies.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age 18 years or older (physician clearance for age > 65)
  • English-speaking
  • Currently Healthy
  • Smoking smoked 5 or more cigarettes/day
  • Must accept randomization procedure
  • BMI< 40
  • Will be Living in RI/MA/CT for next year

Exclusion criteria

  • Participated in any Yoga, Tai Chi, Qi Gong or Mindfulness-based therapy program twice in the past month or 10 times within the past year
  • MD refused consent or Unable to obtain MD consent
  • Unable to attend program due to work or home schedule
  • Currently using medications or in active treatment to quit smoking
  • Currently or planned participation in research or treatment programs that would interfere with this study
  • Presence of health conditions that would make participation in yoga difficult or dangerous

Medical Exclusion Criteria

  • Cardiovascular disease
  • Stroke/TIA
  • Chest pain with physical activity
  • Current or recent (< 6 months) cancer treatment
  • Uncontrolled Hypertension
  • Untreated major depression or hospitalization < six months
  • Bone joint problems
  • Liver or Kidney Disease
  • Fainting within the past year
  • History of seizures
  • Balance condition that interferes with ability to exercise
  • Respiratory Condition - COPD (e.g., emphysema requiring oxygen)
  • Liver Disease
  • Kidney Disease
  • Other medical condition that would interfere with ability to exercise
  • Hypothyroid (not on stable medication for 3 months)

Treatment and study plan

smoking cessation

Behavioral

Once weekly program of cognitive-behavioral therapy for smoking cessation

Yoga

Behavioral

Twice weekly program of 1-hour Iyengar yoga classes

Wellness

Other

Twice weekly program of 1-hour wellness classes on a variety of health topics.

Primary outcomes

  1. Smoking abstinence

    Time frame: One year

    Abstinence from smoking at 1-year post treatment

Sponsors and collaborators

Lead sponsor

The Miriam Hospital

Other

Registry information

Official study title

Efficacy of Yoga as a Complementary Therapy for Smoking Cessation

Important dates

Study start
2012
Primary completion
2016
Study completion
2017
First posted
Mar 13, 2013
Registry last updated
Jul 19, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.